The natural course of non-alcoholic fatty liver disease.
Cirrhosis
non-alcoholic fatty liver disease
steatohepatitis
Journal
Hepatology forum
ISSN: 2757-7392
Titre abrégé: Hepatol Forum
Pays: Turkey
ID NLM: 9918351171306676
Informations de publication
Date de publication:
Jan 2020
Jan 2020
Historique:
received:
02
01
2020
accepted:
16
01
2020
entrez:
11
8
2022
pubmed:
20
1
2020
medline:
20
1
2020
Statut:
epublish
Résumé
The present study aims to describe the characteristics and long-term clinical outcomes of patients with non-alcoholic fatty liver disease (NAFLD). A total of 1308 individuals with NAFLD were seen in the Liver Diseases Outpatient Clinic. Diagnosis of NAFLD in each case was based on biochemical, radiological and histological criteria, when available. After diagnosis, all NAFLD patients were administered a conventional diet and exercise program. The median follow-up period was 55.3 months. At the time of the diagnosis, the mean age was 50.8±11.3 years, and female gender was slightly predominant (51.4%). The median body mass index was 29.2±4.7 kg/m NAFLD is a potentially progressive disease. Diabetes and obesity were associated with the presence of advanced fibrosis.
Sections du résumé
Background and Aim
UNASSIGNED
The present study aims to describe the characteristics and long-term clinical outcomes of patients with non-alcoholic fatty liver disease (NAFLD).
Material and Methods
UNASSIGNED
A total of 1308 individuals with NAFLD were seen in the Liver Diseases Outpatient Clinic. Diagnosis of NAFLD in each case was based on biochemical, radiological and histological criteria, when available. After diagnosis, all NAFLD patients were administered a conventional diet and exercise program. The median follow-up period was 55.3 months.
Results
UNASSIGNED
At the time of the diagnosis, the mean age was 50.8±11.3 years, and female gender was slightly predominant (51.4%). The median body mass index was 29.2±4.7 kg/m
Conclusion
UNASSIGNED
NAFLD is a potentially progressive disease. Diabetes and obesity were associated with the presence of advanced fibrosis.
Identifiants
pubmed: 35949661
doi: 10.14744/hf.2020.0008
pii: hf-1-020
pmc: PMC9344371
doi:
Types de publication
Journal Article
Langues
eng
Pagination
20-24Informations de copyright
© Copyright 2020 by Hepatology Forum.
Déclaration de conflit d'intérêts
The authors have no conflict of interest to declare.
Références
Ann Intern Med. 2002 Jul 2;137(1):49-51
pubmed: 12093245
N Engl J Med. 2002 Apr 18;346(16):1221-31
pubmed: 11961152
Arterioscler Thromb Vasc Biol. 2005 May;25(5):1045-50
pubmed: 15731489
Hepatology. 2004 Dec;40(6):1387-95
pubmed: 15565570
J Clin Invest. 1955 Jan;34(1):126-31
pubmed: 13221663
Gastroenterology. 1999 Jun;116(6):1413-9
pubmed: 10348825
Acta Med Scand. 1964 Jan;175:49-56
pubmed: 14110637
Diabetologia. 1985 Jul;28(7):412-9
pubmed: 3899825
Clin Gastroenterol Hepatol. 2009 Feb;7(2):234-8
pubmed: 19049831
Hepatology. 2003 Aug;38(2):420-7
pubmed: 12883486
Curr Opin Lipidol. 2005 Aug;16(4):421-7
pubmed: 15990591
Hepatology. 2004 Apr;39(4):1172; author reply 1173
pubmed: 15057921
Semin Liver Dis. 2008 Nov;28(4):339-50
pubmed: 18956290
Ann Intern Med. 2002 Jul 2;137(1):1-10
pubmed: 12093239
Gastroenterology. 2001 Apr;120(5):1183-92
pubmed: 11266382
Hepatology. 2005 Jun;41(6):1313-21
pubmed: 15915461
Clin Liver Dis. 2009 Nov;13(4):511-31
pubmed: 19818302
Hepatology. 2005 Sep;42(3):650-6
pubmed: 16037946
Hepatology. 1995 Dec;22(6):1714-9
pubmed: 7489979
Gastroenterology. 1994 Oct;107(4):1103-9
pubmed: 7523217
Semin Liver Dis. 2001;21(1):27-41
pubmed: 11296694
J Hepatol. 1997 Jul;27(1):103-7
pubmed: 9252081
Hepatology. 1998 May;27(5):1213-9
pubmed: 9581673
Am J Gastroenterol. 1999 Sep;94(9):2467-74
pubmed: 10484010
Gastroenterology. 2003 Jan;124(1):71-9
pubmed: 12512031
J Hepatol. 2009 Aug;51(2):371-9
pubmed: 19501928
Hepatology. 2003 May;37(5):1202-19
pubmed: 12717402
Gastroenterology. 2005 Jul;129(1):113-21
pubmed: 16012941
Hepatology. 2003 Jun;37(6):1286-92
pubmed: 12774006
Aliment Pharmacol Ther. 2007 Sep 15;26(6):821-30
pubmed: 17767466
Turk J Gastroenterol. 2019 Oct;30(10):892-898
pubmed: 31258138
Metabolism. 2002 Aug;51(8):1071-6
pubmed: 12145784
Hepatology. 2003 Apr;37(4):917-23
pubmed: 12668987
Gut. 2004 May;53(5):750-5
pubmed: 15082596
Hepatology. 2006 Oct;44(4):865-73
pubmed: 17006923
Ann Clin Res. 1982;14 Suppl 34:80-5
pubmed: 7149635
Gastroenterology. 2002 Sep;123(3):745-50
pubmed: 12198701
Gut. 2009 Nov;58(11):1538-44
pubmed: 19625277